INTRODUCTION
Physiological changes in pregnant women can lead to poor dietary behaviour which may have negative repercussions on the mother and developing fetus.
Policymakers, development partners and healthcare service providers have sought to reduce maternal and infant mortality and child birth complications, both of which are major public health concerns in most developing countries. 1 Adequate nutrition is essential during pregnancy as nutrition is an important factor in the health of the mother and the health, growth and development of the fetus. [2] [3] [4] Weight gain is expected in pregnancy, with Mahan et al 5 reporting that healthy weight gain impacts positively on pregnancy outcomes. It has also been reported elsewhere 2 that suitable prenatal weight gain is associated with a lower risk of complications during pregnancy and birth. However, further research is required as data on the association between prenatal dietary patterns and birth weight are scanty and findings are inconsistent. 6 The usual dietary intake of pregnant women is a key determinant of nutritional status and of nutrient depletion during pregnancy, which is a risk factor for reduced fetal
Strengths and limitations of this study
▪ Study subjects will be easily recruited at the antenatal care units of the selected health facilities. ▪ Some study participants may be lost to follow-up. ▪ Random and systematic errors may occur in the dietary assessment as some pregnant women may not be able to remember all foods consumed during the recall period. ▪ Some respondents may try to impress the researcher by mentioning foods that they have or have not consumed. ▪ To control for the limitations mentioned above, study subjects will be introduced to the researchers and the importance of the information and study will be emphasised.
growth and poor pregnancy outcome. Nevertheless, how maternal dietary diversity (DD) during pregnancy impacts on birth weight is unclear and data on the DD of pregnant women in Ghana are limited.
A number of studies in developed countries have linked DD to nutrient intake, particularly among adults. The Dietary Diversity Score (DDS) is a simple and inexpensive tool for assessing diet quality, 7 and recent focus on nutritional epidemiology has shifted from examining the effect of single nutrients to assessing overall diet quality. 8 Nevertheless, few studies have investigated the association between DD and pregnancy outcomes, although Saaka 9 found that maternal DD was an independent predictor of birth weight in Ghana. However, his study used a cross-sectional design which has the inherent weakness of inability to measure order of exposure and subject outcome. DD has also been shown to be strongly associated with household socioeconomic status, and associations between socioeconomic status and child nutrition and health outcomes have long been recognized. 9 Understanding the associations between DD and pregnancy outcomes is therefore complicated by household socioeconomic factors.
This study therefore aims investigate the role of DD in determining pregnancy outcomes among women in a low socioeconomic environment.
Objectives
The main aim of this study is to compare ?pregnancy outcomes in women with low and high DD in Northern Ghana. The study shall also compare: i. The demographic and socioeconomic characteristics (age, educational status, occupation, marital status, household size and household assets) of pregnant women in the two groups at the beginning of the study ii. Maternal history ( parity, gravida, still birth, abortion) of pregnant women in the two groups at the beginning of the study iii. (iii) The physical activity level, energy and nutrient intake of the two groups at the beginning and end of the study iv. The weight, height, body mass index (BMI), mid upper arm circumference (MUAC),and systolic and diastolic pressure of the two groups at the beginning and end of the study v. Pregnancy outcomes including gestational weight gain, birth weight, low birthweight (LBW) rate, pregnancy complications, birth complications (Apgar scores), preterm delivery and type of delivery, of the two groups at the end of the study.
METHODS AND DESIGN Study design
A prospective cohort study design will be used. Study participants will be recruited during the first trimester (10-12 weeks) of their pregnancies and followed until delivery so that the incidence of outcomes and associations between exposure and outcome variables among the study participants can be measured.
Study subjects
The study subjects will be pregnant women attending an antenatal care (ANC) clinic in health facilities in Northern Ghana from the first trimester of their pregnancies.
Inclusion criteria ▸ Pregnant women aged 20-49 years ▸ Pregnant women in the first trimester (10-12 weeks) ▸ Willingness of the mother to be delivered in a health facility ▸ Willingness to participate in the study ▸ Resident in the study area for at least 1 year.
Exclusion criteria ▸ Women with high risk pregnancies or special needs who require specialist care or with a history of highrisk pregnancies ▸ Women with recurrent miscarriages or treated for infertility ▸ Women with a history of spontaneous or therapeutic abortion due to neural tube defects (NTD) ▸ Women with known diseases (HIV, diabetes type II, renal disease, cardiovascular disease, confirmed malaria and other chronic disease) or on regular medication ▸ Women still experiencing persistent severe nausea with vomiting by the 12th week of pregnancy ▸ Women with an ultrasound scan results showing more than one fetus.
Sample size determination A single population proportion sample estimation formula was used to calculate the sample size for this study as follows:
n, Required minimum sample size; z, degree of confidence with which it is desired to be able to conclude that an observed change of size; a, margin of error (level of statistical significance); p, prevalence ( proportion) of outcome variable of measure; d, precision of detecting change. This formula was used because this is a populationbased cohort study where a defined population is usually selected first, some of whose participants will be exposed (DDS) while others will not.
Main study population
Using the formula and based on an estimated prevalence of LBW of 17% (0.17) according to a study in Northern Ghana, 9 an α error (level of statistical significance, 0.05) of 5%, and 18% precision) of LBW of 0.031, the estimated sample size is 579 with a 95% confidence level. To allow for 5% attrition or loss to follow-up, the final estimated sample size is 600. As we anticipate that approximately 30-40% of the 600 women will have low DDS, we will compare the outcomes of 240 women with low DDS with those of 360 women with high DDS.
Sampling
The three main hospitals (one teaching hospital and two district hospital) in the Northern Region of Ghana together with three primary health centres in Tamale, the capital of the region, will be used for recruitment and data collection. The number of subjects to be recruited from each health facility will be in proportion to the size of the centre.
A systematic random sampling technique will be used to select study participants. The first study subject will be selected randomly using a random number table, with following subjects selected according to a predetermined sampling interval until the required sample is completed.
Recruitment
Pregnant women in their first trimester (10-12 weeks) will be systematically recruited at the reproductive and child health units (where antenatal clinics are held) of the health facilities using the ANC register of the facility. The gestational age of the fetus will be determined by ultrasound in conjunction with the date the woman gives for her last menstrual period (LMP). Only those who meet the inclusion criteria will be enrolled.
Data collection
Both primary and secondary data will be gathered in this study. The general information of subjects together with predictors, outcome variables and potential confounding variables will be collected.
General information
Sociodemographic and general data will be collected using a structured questionnaire. Secondary data including maternal health history and delivery records will be obtained from Maternal Health Record Book (MHRB) and the delivery records of the study participants using a checklist.
Physical activity measurements
The International Physical Activity Questionnaire (IPAQ-2005, short form) will be used to assess the physical activity of study subjects across different domains including leisure time and domestic, work and transport-related physical activity. 10 Dietary intake assessment A 24-hour food recall will be conducted to measure the nutrient adequacy of study subjects. Participants will be asked for a complete list of all items used in the preparation of meals. Estimates of the quantity of foods consumed will be recorded. Dietary information will be collected three times and the mean computed for nutrient estimations. The information on individual food items and portion sizes will then analysed to estimate nutrient adequacy. The 24-hour recall data will be collected with the help of a research assistant.
Minimum DD-women indicator DD for this study will be calculated using the minimum DD-women (MDD-W) indicator which is an improved version of the Women's Dietary Diversity (WDD) score and has 10 food groups, consumption of at least 5 of which indicates high DD.
11 DD will be measured three times using a 24-hour food recall and the overall mean of the three scores for all women will be used to define low and high DD.
Anthropometric measurements
At each visit participants will be weighed without shoes and with minimal or light clothing using a Seca scale. Readings will be taken to the nearest 100 g.
The height of participants will be measured only once (at recruitment) using a Seca Microtoise. Subjects will be measured to the nearest 0.1 cm while standing without shoes.
MUAC will be measured at each visit to assess wasting among study subjects using an adult MUAC nonstretchable measuring tape. The reading will be taken to the nearest 0.1 cm while the left arm relaxes along the body trunk. MUAC measurements below 23 cm will be classified as wasting and those above 23 cm as normal. 12 BMI will be computed and used to assess nutritional status and the gestational weight gain of the women. Subjects with a BMI of <18.5 kg/m 2 , 18.5-24.9 kg/m 2 , 25-29.9 kg/m 2 or ≥30 kg/m 2 will be classified as underweight, normal, overweight or obese, respectively. 13 The Institute of Medicine (IOM) recommended guidelines 14 will be used to estimate gestational weight gain. Women who are underweight, normal, overweight and obese are expected to gain 12.7-18.2 kg, 11.4-15.9 kg, 6.8-11.4 kg and 5-9.1 kg gestational weight, respectively, before delivery.
Blood pressure measurements
Blood pressure of subjects will be measured to the nearest 0.5 mm Hg using a digital arm sphygmomanometer after a 10 min rest while in a supine position. Measurements will be performed at each visit.
Measurement of pregnancy outcomes
Pregnancy outcome records will be obtained from physician's notes on the MHRB after delivery and/or the woman herself using a simple checklist.
Follow-up
There will be three follow-up visits after recruitment. Two (at 22-24 weeks and 36-37 weeks of gestation) will be during the pregnancy and the third after delivery. Sociodemographic and general information will be collected at recruitment. Dietary intake and physical activity will be measured at recruitment and the first two follow-up visits (at 22-24 and 36-37 weeks). Weight, MUAC, and systolic and diastolic blood pressure will be measured at recruitment and at each visit, while height will only be measured once at recruitment.
Variable and potential confounders
The primary outcomes variables that will be measured in this study are pregnancy weight gain before delivery and birth weight. The secondary outcomes variables will include pregnancy complications ( pre-eclampsia), birth complications (asphyxia/Apgar scores), preterm delivery and type of delivery. DDS and amount of nutrient intake will be measured as the anticipated predictor variables of the primary and secondary outcome variables. The potential confounding variables that will be measured include age, educational status, marital status, occupation, household size, socioeconomic status (household wealth index), maternal history (eg, parity, G6PD status, still birth, abortion and gravida), smoking, alcohol intake, pica, dietary supplementation, craving for certain foods, cultural practices, BMI and physical activity.
Data analysis
Data will be cleaned, entered into a computer database and analysed using SPSS V.22 (SPSS, Chicago, Illinois, USA). Univariate, bivariate and multivariate analyses will be performed on the variables and 95% confidence levels will be set to test for significance. The data will first be analysed using descriptive statistics. Frequency tables will be produced for different variables and cross tabulations will be performed accordingly. Comparison between groups (categorical data) will be done using χ 2 tests for proportions, and t-tests and ANOVA will be used on continuous variables. Regression analysis will be performed to identify independent outcome predictors while controlling for possible confounding factors. Relative risks at 96% CI will be computed to ascertain the presence and degree of association between independent and dependent variables.
The nutritional intake of each food item will be converted into g/day. Information from the 24-hour food recall will be converted into quantities (quantitative data) of nutrient intakes using Ghana's food composition table and food processor software. The recommended nutrient intake (RNI) will be used to assess the nutrient adequacy of diets.
Ethical issues and informed consent process
The study protocol has received approval from the ethics committee of Tehran University of Medical Sciences (IR.TUMS.REC.1394.495) and Tamale
Teaching Hospital (TTH/10/11/15/01). The investigators will provide study subjects with all the information they need to participate in the study through an informed consent form, which will be read to those not able to read in English by the interviewer in the presence of a witness. The consent form will be signed or marked with the thumb print of the subject and signed by the interviewer and investigator. Only those who give their consent will be included in the study.
DISCUSSION
Maternal diet during pregnancy may influence pregnancy and childhood outcomes, such as length of gestation, fetal growth, birth defects, pre-eclampsia, gestational diabetes and the offspring's cognitive development, blood pressure, adiposity and atopic disease.
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Bodnar and Siega-Riz 26 observed that diet quality can be measured by assessing dietary intake and determining whether it reflects the recommendations for pregnancy established by the United States Department of Agriculture and the IOM. An increase in DD has therefore been advocated as a way to improve micronutrient status in populations because it offers some benefits not provided by supplements during pregnancy. 27 28 The available literature [29] [30] [31] suggests that diet quality before and during pregnancy can affect pregnancy outcome. An observational study in India showed that rural mothers who consumed foods rich in micronutrients (green leafy vegetables, fruit, and milk) gave birth to infants who were heavier and larger than the children of mothers who did not. 32 Other studies suggested that diet quality in pregnant women should be examined. 33 34 The results of the literature search revealed that little is known about DD and pregnancy outcomes, particularly in low socioeconomic environments.
